Tradestie Institutional Equity Comparison Engine

BHST vs ACOG โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ACOG Overall Edge

ACOG Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Alpha Cognition Inc. Common Stock (ACOG) driven by superior Valuation, Momentum & Technical, Options & Structure while BHST counters with relative strength in Growth & Margin. Fundamentally, BHST trades at N/M Forward P/E with -18.0% operating margin (+3.8% YoY revenue) versus ACOG at 26.9x Forward P/E and -141.6% operating margin (+173.8% YoY). In options structure, BHST sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ACOG sits in CONSOLIDATION (50th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ACOG
BHST N/M vs ACOG 26.9x Fwd P/E
Growth & Margin Winner BHST
Op Margin -18.0% vs -141.6% ยท YoY +3.8% vs +173.8%
Momentum & Technical Winner ACOG
1Y -79.4% vs +52.0% ยท 52W Pos 6% vs 80%
Options & Structure Winner ACOG
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (50th %ile IV)
BHST NASDAQ
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap $29.9M
1M Return -22.62%
1Y Return -79.4%
Forward P/E N/M
Unified AI Score
58.2 / 100 HOLD
Tech 75.0 Fund 57.0 Flow 50.0 Mom 60.0
ACOG NASDAQ
Alpha Cognition Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$9.00
+1.69% 1D
Market Cap $195.1M
1M Return +8.3%
1Y Return +52.03%
Forward P/E 26.9x
Unified AI Score
56.2 / 100 HOLD
Tech 38.0 Fund 55.0 Flow 69.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BHST -79.4% ACOG +52.03% Spread: +131.43 pp (ACOG Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period BHST Revenue ACOG Revenue BHST Op. Margin ACOG Op. Margin Margin Edge
FY2023 $10M N/A -78.6% N/A BHST
FY2024 $30M N/A -27.7% N/A BHST
FY2025 $30M $10M -16.2% -221.7% BHST

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BHST (3) vs ACOG (7)
Institutional Metric BHST ACOG Criterion Row Winner
Market Capitalization Scale $29.9M $195.1M Larger Scale ACOG
Trailing P/E Ratio Valuation N/M 26.9x Lower Multiple ACOG
Forward P/E Ratio Valuation N/M 26.9x Lower Multiple ACOG
Revenue Growth (YoY) Growth +3.8% +173.8% Higher Growth ACOG
Operating Margin (TTM) Profitability -18.0% -141.6% Higher Margin BHST
Net Profit Margin Profitability -31.2% -139.2% Higher Margin BHST
Return on Equity (ROE) Capital Efficiency -142.5% -67.6% Higher ROE ACOG
52-Week Range Position Momentum 6% ($1โ€“$7) 80% ($4โ€“$10) Stronger Trend ACOG
Beta / 30D Volatility Risk Regime 0.25ฮฒ ยท 86% Vol 0.75ฮฒ ยท 63% Vol Lower Realized Risk ACOG
Unified Institutional Score Composite Signal 58.2 / 100 (HOLD) 56.2 / 100 (HOLD) Higher Composite BHST

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BHST vs ACOG Buy Guide
BHST UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BHST Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ACOG CONSOLIDATION
64d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ACOG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BHST nor ACOG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.